Development of two Salmonella-based oral vaccines against human respiratory syncytial virus
Human respiratory syncytial virus is the most common cause of bronchiolitis and other respiratory infections in infants and the elderly worldwide. We have developed two new oral vaccines using Salmonella typhi TY21a to carry and express the immunogenic epitopes of RSV fusion (F) and attachment (G) g...
Автори: | Jalilian, F. Azizi, Yusoff, K., Suhaimi, S., Amini, R., Sekawi, Z., Jahanshiri, F. |
---|---|
Формат: | Стаття |
Опубліковано: |
BIOLIFE, s.a.s.
2015
|
Схожі ресурси
Схожі ресурси
-
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
за авторством: Suhaimi, Siti Syazani
Опубліковано: (2011) -
Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
за авторством: Jalilian, Farid Azizi
Опубліковано: (2011) -
Vaccination against respiratory syncytial virus
за авторством: Green, CA, та інші
Опубліковано: (2020) -
Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
за авторством: Jalilian, Farid Azizi, та інші
Опубліковано: (2011) -
Respiratory syncytial virus vaccination during pregnancy and effects in infants
за авторством: Madhi, SA, та інші
Опубліковано: (2020)